Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.R900011-JLR200 on May 5, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
R900011-JLR200v1
50/9/1721    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Amaral, J. D.
Right arrow Articles by Rodrigues, C. M. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amaral, J. D.
Right arrow Articles by Rodrigues, C. M. P.
Related Collections
Right arrow Related Webpages
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 50, 1721-1734, September 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology


Thematic Review

Thematic Review Series: Bile Acids

Bile acids: regulation of apoptosis by ursodeoxycholic acid

Joana D. Amaral*, Ricardo J. S. Viana*, Rita M. Ramalho*, Clifford J. Steer{dagger} and Cecília M. P. Rodrigues1,*

* Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
{dagger} Departments of Medicine, and Genetics, Cell Biology, and Development, University of Minnesota Medical School, Minneapolis, MN

1 To whom correspondence should be addressed. e-mail: cmprodrigues{at}ff.ul.pt

Bile acids are a group of molecular species of acidic steroids with peculiar physical-chemical and biological characteristics. At high concentrations they become toxic to mammalian cells, and their presence is pertinent in the pathogenesis of several liver diseases and colon cancer. Bile acid cytoxicity has been related to membrane damage, but also to nondetergent effects, such as oxidative stress and apoptosis. Strikingly, hydrophilic ursodeoxycholic acid (UDCA), and its taurine-conjugated form (TUDCA), show profound cytoprotective properties. Indeed, these molecules have been described as potent inhibitors of classic pathways of apoptosis, although their precise mode of action remains to be clarified. UDCA, originally used for cholesterol gallstone dissolution, is currently considered the first choice therapy for several forms of cholestatic syndromes. However, the beneficial effects of both UDCA and TUDCA have been tested in other experimental pathological conditions with deregulated levels of apoptosis, including neurological disorders, such as Alzheimer's, Parkinson's, and Huntington's diseases. Here, we review the role of bile acids in modulating the apoptosis process, emphasizing the anti-apoptotic effects of UDCA and TUDCA, as well as their potential use as novel and alternate therapeutic agents for the treatment of apoptosis-related diseases.

Supplementary key words Bcl-2 family • cell death • liver • neuroprotection • nuclear steroid receptors

Abbreviations: Aβ, amyloid β; AP-1, activating protein-1; CDK, cyclin-dependent kinase; C/EBPβ, CCAAT enhancer binding protein β; CREB, cyclic AMP-response element binding protein; CYP7A1, cholesterol 7{alpha}-hydroxylase; CYP8B1, cholesterol 12{alpha}-hydrolase; DCA, deoxycholic acid; ER, endoplasmic reticulum; ERK, extracellular-regulated kinase; FADD, Fas-associated death domain; FGF19, fibroblast growth factor intestine 19; FGFR4, fibroblast growth factor receptor 4; FXR, farnesoid X receptor; GC, glucocorticoid; GCDCA, glycochenodeoxycholic acid; GR, glucocorticoid receptor; JNK, c-Jun NH2-terminal kinase; LBD, ligand binding domain; LRH-1, liver receptor homolog-1; MAPK, mitogen-activated protein kinase; MR, mineralcorticoid receptor; NF-{kappa}B, nuclear factor {kappa}B; NSR, nuclear steroid receptor; PC12, pheochromocytoma; PI3K, phosphatidylinositol 3-kinase; pRb, retinoblastoma protein; PXR, pregnane X receptor; ROS, reactive oxygen species; RSK, ribosomal S6 kinase; SHP, small heterodimer partner; TGF-β1, transforming growth factor β1; TNF, tumor necrosis factor; TRAIL, TNF-related apoptosis inducing ligand; TTR, transthyretin; TUDCA, tauroursodeoxycholic acid; UDCA, ursodeoxycholic acid


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


Related Webpages:

Part of the JLR Thematic Review Series on Bile Acids




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement